TNGX
Tango Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$22.64
−0.53%Margins
Gross margin
98.2%
EBITDA margin
-227.3%
EBIT margin
-253.4%
Net margin
-229.9%
FCF margin
-268.1%
-12.1%
Return on equity
-11.5%
Return on assets
-12.9%
Return on invested capital
0.07x
Asset turnover
-$143.9M
Cash from operations
$6.01
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026